Maria A Jiménez-Santos1, Federico Saénz-Francés2, Rubén Sánchez-Jean2, José María Martinez-de-la Casa2,3, Julian García-Feijoo2,3, Luis Jañez-Escalada4. 1. Ophthalmology Department, Hospital Clinico San Carlos, C/ Martín Lagos s/n, Madrid, Spain. mariajimenezsantos@gmail.com. 2. Ophthalmology Department, Hospital Clinico San Carlos, C/ Martín Lagos s/n, Madrid, Spain. 3. Ophthalmology Department, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain. 4. Laboratorio de Vision, Instituro de Tecnología del Conocimiento, Facultad de Psicología, Universidad Complutense de Madrid, Madrid, Spain.
Abstract
PURPOSE: To evaluate corneal hysteresis (CH), acquired with ocular response analyzer (ORA), as a risk factor for glaucoma progression in early-stage primary open-angle glaucoma (POAG). METHODS: In a historical cohort study, patients diagnosed in 2011 with early-stage POAG according to the Hodapp, Parrish and Anderson classification modified for Octopus perimetry and followed up until glaucomatous progression development; otherwise, observations were censored in October 2018. Cox regression was used to obtain hazard ratios (HR) to evaluate baseline variables (CH, central corneal thickness, gender, age IOP and glaucoma family history) as risk factors for perimetric glaucoma progression. A likelihood ratio test for interaction was performed in order to assess the effect of the combination of CH and CCT on the risk of progression. RESULTS: Of the cohort of 1573 patients, 11.38% developed early-stage POAG progression during the follow-up. The mean follow-up time was 3.28 ± 1.92 years. Patients without progression had a higher CH (11.35 ± 1.43 vs 9.07 ± 1.69 mmHg; p < 0.001) and CCT (570.75 ± 17.71 vs 554.51 ± 23.20; p < 0.001). In the multivariate analysis, each 1 mmHg of lower CH was associated with an increase of 2.13 times in the HR of progression (95% CI: 1.92-2.32; p < 0.001). CH hazard ratio was modified by CCT, with higher values of CCT and CH resulting in a higher HR of early glaucoma progression (p < 0.001). CONCLUSIONS: CH can be considered as a risk factor of progression in early-stage POAG. The risk associated with CH changed depending on CCT values, acting synergistically slowing the risk of glaucoma progression with higher values.
PURPOSE: To evaluate corneal hysteresis (CH), acquired with ocular response analyzer (ORA), as a risk factor for glaucoma progression in early-stage primary open-angle glaucoma (POAG). METHODS: In a historical cohort study, patients diagnosed in 2011 with early-stage POAG according to the Hodapp, Parrish and Anderson classification modified for Octopus perimetry and followed up until glaucomatous progression development; otherwise, observations were censored in October 2018. Cox regression was used to obtain hazard ratios (HR) to evaluate baseline variables (CH, central corneal thickness, gender, age IOP and glaucoma family history) as risk factors for perimetric glaucoma progression. A likelihood ratio test for interaction was performed in order to assess the effect of the combination of CH and CCT on the risk of progression. RESULTS: Of the cohort of 1573 patients, 11.38% developed early-stage POAG progression during the follow-up. The mean follow-up time was 3.28 ± 1.92 years. Patients without progression had a higher CH (11.35 ± 1.43 vs 9.07 ± 1.69 mmHg; p < 0.001) and CCT (570.75 ± 17.71 vs 554.51 ± 23.20; p < 0.001). In the multivariate analysis, each 1 mmHg of lower CH was associated with an increase of 2.13 times in the HR of progression (95% CI: 1.92-2.32; p < 0.001). CH hazard ratio was modified by CCT, with higher values of CCT and CH resulting in a higher HR of early glaucoma progression (p < 0.001). CONCLUSIONS: CH can be considered as a risk factor of progression in early-stage POAG. The risk associated with CH changed depending on CCT values, acting synergistically slowing the risk of glaucoma progression with higher values.
Authors: Claude F Burgoyne; J Crawford Downs; Anthony J Bellezza; J-K Francis Suh; Richard T Hart Journal: Prog Retin Eye Res Date: 2005-01 Impact factor: 21.198
Authors: Carolina N Susanna; Alberto Diniz-Filho; Fábio B Daga; Bianca N Susanna; Feilin Zhu; Nara G Ogata; Felipe A Medeiros Journal: Am J Ophthalmol Date: 2018-01-02 Impact factor: 5.258
Authors: Carlos V Gustavo De Moraes; Victoria Hill; Celso Tello; Jeffrey M Liebmann; Robert Ritch Journal: J Glaucoma Date: 2012 Apr-May Impact factor: 2.503
Authors: Anthony P Wells; David F Garway-Heath; Ali Poostchi; Tracey Wong; Kenneth C Y Chan; Nisha Sachdev Journal: Invest Ophthalmol Vis Sci Date: 2008-03-03 Impact factor: 4.799
Authors: Nathan G Congdon; Aimee T Broman; Karen Bandeen-Roche; Davinder Grover; Harry A Quigley Journal: Am J Ophthalmol Date: 2006-03-09 Impact factor: 5.258
Authors: Felipe A Medeiros; Daniel Meira-Freitas; Renato Lisboa; Tung-Mei Kuang; Linda M Zangwill; Robert N Weinreb Journal: Ophthalmology Date: 2013-05-01 Impact factor: 12.079